“As someone deeply passionate about Tregs and Treg-targeted therapies, I’m thrilled to attend and chair the 7^th Treg-Directed Therapies Summit, where we’ll explore the cutting-edge advances in immune modulation. I look forward to hearing great talks, exchanging ideas with fellow experts, and pushing the boundaries of what’s possible in this rapidly evolving field!”
– Fabien Depis, Independent Expert, 2025 Speaker

“The 7^th Treg-Directed Therapies Summit allows for robust and engaging discussions with the leaders in the regulatory T-cell space. Regulatory T-cells present significant challenges and opportunities that are unique and distinct from other cell therapy modalities and having a unified summit to discuss these topics presents an amazing opportunity to advance the field.”
– James Adams, Chief Technology Officer, Tr1x Bio, 2025 Speaker

“I am excited to be hearing about progress and discuss challenges in developing regulatory T cell-based therapies for prevention of transplant rejection and treatment of autoimmune and inflammatory conditions.”
 – Joseph Leventhal, Scientific Founder, Tract Therapeutics, 2025 Speaker